| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | CHIEF EXECUTIVE OFFICER, Director | Common Stock, $0.01 par value | 133K | $27.2M | $205.02 | Feb 28, 2025 | Direct |
| AbbVie Inc. | CHIEF EXECUTIVE OFFICER, Director | Option (Right to Buy) | 83.3K | $7.79M | $93.50 | Feb 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | Feb 28, 2025 | 1 | -$5.57M | 4 | Mar 4, 2025 | CHIEF EXECUTIVE OFFICER, Director |
| ABBV | AbbVie Inc. | Feb 13, 2025 | 5 | $0 | 4 | Feb 18, 2025 | CHIEF EXECUTIVE OFFICER, Director |
| ABBV | AbbVie Inc. | Feb 28, 2024 | 7 | -$18.9M | 4 | Mar 1, 2024 | PRES & CHIEF OPERATING OFFICER |
| ABBV | AbbVie Inc. | Feb 15, 2024 | 5 | $0 | 4 | Feb 20, 2024 | PRES & CHIEF OPERATING OFFICER |
| ABBV | AbbVie Inc. | Feb 28, 2023 | 1 | -$7.46M | 4 | Mar 2, 2023 | VICE CHAIRMAN |
| ABBV | AbbVie Inc. | Feb 16, 2023 | 5 | $0 | 4 | Feb 21, 2023 | VICE CHAIRMAN |
| ABBV | AbbVie Inc. | Feb 25, 2022 | 4 | -$11.5M | 4 | Mar 1, 2022 | Vice Chairman |
| ABBV | AbbVie Inc. | Feb 17, 2022 | 5 | $0 | 4 | Feb 22, 2022 | Vice Chairman |